Friday, 13 Jul 2018

You are here

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings.  Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

  1. Metanalysis of checkpoint inhibitor (nivolumab, pembrolizumab or atezolizumab) shows high rates of hypothyroidism (OR 7.6), pneumonitis (5.4), colitis (2.9), hypophysitis (3.4), rash (2.4), fatigue (32%), diarrhea (19%) and  a >20% frequency of arthraligia or back pain. https://t.co/1WMuRRCWZN
  2. Science Translocation of a gut microbe, Enterococcus gallinarum to tissues triggers autoimmunity in mice with a genetic predispositon to lupus. Vancomycin prevented mortality by suppressing E. gallinarum and eliminating pathogenic autoantibodies and T cells. https://t.co/02vZstzQ86
  3. An Italian 89 pt GPA study finds ENT involvement in 72%; they tend to be younger with less renal disease. Sinonasal symptoms were seen in 58% and otitis media/otomastoiditis in 35%. ENT involvement predicted better outcomes and milder GPA with risk of lower renal disease and mortality rate. https://t.co/UWjzzloxm9
  4. Comparing patients who travel by air vs. those by land to/from hospital after TKR, THR, finds 3 fold higher rates of venous thromboembolic events (VTE) (1.64% vs 0.58%) https://t.co/n5cu9eeqz6
  5. Opportunistic Infections in RA Rare with Biologics   
  6. Bone Marrow Edema Found in SI Joint of Athletes  
  7. Plaquenil During Lupus Pregnancy Lessens Flares 
  8. CARES Study- More CV Deaths with Febuxostat 

“A goal without a plan is just a wish.” ― Antoine de Saint-Exupéry (goals specific, measureable, attainable, realistic & timely - Christine Bundy)

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Rheumatologists' Comments

Many gout patients placed on febuxostat due to renal diseases. Could presence kidney problems raise risk adverse cardiovascular events for those on febuxostat?

More Like This

The RheumNow Week in Review –Fateful Outcomes in Rheumatology (7.13.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:

The RheumNow Week in Review – Life Savers for Rheumatologists (6.29.18)

Dr. Jack Cush reviews selected news and journal reports from the past week on RheumNow.com.

The RheumNow Week in Review – EULAR18 Epilogue (6.22.18)

Dr. Jack Cush reviews EULAR 2018 and the past week's news and reports from RheumNow.com, including DMARDs in OA, the price of Penicillamine, Infections when ANCA+, CV outcomes in gout, NSAIDs in Pregnancy and Seropostive vs. Seronegative Outcomes.

CDC Obesity Prevalence Higher in the Rural USA

MMWR reports that approximately 46 million persons (14%) in the United States live in nonmetropolitan counties, where there is a higher prevalence of obesity-associated chronic diseases such as diabetes, coronary heart disease, and arthritis. (Citation source: http://bit.ly/2lj5yql)

EULAR 2018 - Podcast from Day 4

This EULAR 2018 Podcast is a compilation of audio clips from EULAR in Amsterdam.

Click HERE to listen.

You can also listen on iTunes, Soundcloud or Stitcher.